Connect through your story: https://bit.ly/4oww4dV
#ALSNewsToday #Bionews #ALSCommunity #ALSAwareness #LivingWithALS #ALSCaregivers #EndALS #ALSResearch #ALSSupport #RareDiseaseCommunity
0
0
0
0
#ALSResearch
Latest posts tagged with #ALSResearch on Bluesky
Trending
Posts tagged #ALSResearch
Chen Eitan, PhD was awarded the 2026 Richard Olney Next Generation Research Grant in ALS. Dr. Eitan will use gene therapy techniques to test whether boosting or reducing certain gene expressions will correct dysfunction of a protein called TDP43. This research could lead to a new class of treatments addressing ALS at its root. This research is co-funded with The ALS Association.
Chen Eitan, PhD was awarded the 2026 Richard Olney Next Generation Research Grant in #ALS.
Institution: National Institute of Neurological Disorders and Stroke (NINDS)
This research is co-funded with @alsassociation.bsky.social.
More ➡️ buff.ly/eFDuBY9
#ALSResearch
2
0
1
0
Rebecca Casterton, PhD was awarded a 2026 Next Generation Research Grant in ALS. Dr. Casterton will focus on changes to the cell cycles of neurons and how changes to these patterns could be relevant in treating a genetically inherited form of ALS. She will also study whether an existing cancer drug can prolong motor neuron survival. This research is co-funded with The ALS Association.
Rebecca Casterton, PhD was awarded a Next Generation Research Grant in #ALS.
Institution: University of Cape Town, South Africa
This research is co-funded with @alsassociation.bsky.social.
More ➡️ buff.ly/I9V0U7d
#ALSResearch
2
0
1
0
ALS News Today: fat-based bubbles carrying GMI cross the blood–brain barrier in mice, improving movement and survival.
Bubbles & a big idea: https://bit.ly/4boHf4d
Researchers are exploring a new strategy that uses microscopic fat-based bubbles to carry a nerve-protecting molecule directly into the brain.
#ALS #ALSResearch #ClinicalResearch #Bionews #ALSNewsToday
0
0
0
0
Read about ALS fatigue: https://bit.ly/3WJuQQh
From pacing your day to adjusting routines, small changes can help preserve energy and peace of mind.
#ALSNewsToday #ALSCommunity #ALS #AmyotrophicLateralSclerosis #FatigueAwareness #ALSSymptoms #ALSResearch #RareDiseaseCommunity #Bionews
1
0
0
0
Paul Seaver holding a photo of his father, Paul “Wally” Seaver. Photo courtesy of Paul Seaver
Paul Seaver with his father Paul “Wally” Seaver. Photo courtesy of Paul Seaver
Boston Marathon runners on the UMass ALS Cellucci Fund Boston Marathon Team have raised nearly $1 million for ALS research since 2012. First-timer Paul Seaver is running as a tribute to his dad. Read his story: https://direc.to/oY6B
#BostonMarathon #BostonMarathon2026 #ALS #ALSresearch #RunForACure
0
0
0
0
Early PrimeC treatment extended ALS patient survival >14 months and reduced death risk by 65% versus delayed treatment.
Promising results emerging: https://bit.ly/4scGmkZ
Early treatment with PrimeC was linked to longer survival in people with ALS compared with delayed treatment, based on long term data.
#ALSResearch #ALSAwareness #HopeInResearch #Bionews #ALSNewsToday
0
0
0
0
Study links a bacterial gut sugar to ALS-related inflammation; breaking it down reduced inflammation and improved survival in mice.
New gut clue: https://bit.ly/4rWEPiM
Researchers have identified an unusual bacterial sugar in the gut that may contribute to inflammation linked to ALS, opening a potential new path for future therapies.
#ALS #ALSAwareness #ALSResearch #GutHealth #ALSToday #ALSNewsToday #Bionews
1
0
1
0
Read about ALS fatigue: https://bit.ly/3WJuQQh
From pacing your day to adjusting routines, small changes can help preserve energy and peace of mind.
#ALSNewsToday #ALSCommunity #ALS #AmyotrophicLateralSclerosis #FatigueAwareness #ALSSymptoms #ALSResearch #RareDiseaseCommunity #Bionews
1
0
0
0
GAO report reveals a $276M surge in #ALS treatment investment — new funding data, priorities & what it means for patients and research. Dive into the full breakdown and implications: https://f.mtr.cool/ttmvcaazxp #ALSResearch
0
0
0
0
GAO report reveals a $276M surge in #ALS treatment investment — new funding data, priorities & what it means for patients and research. Dive into the full breakdown and implications: https://f.mtr.cool/iyfpvsppwj #ALSResearch
0
0
0
0
Why this ALS risk? https://bit.ly/4agCvNG
If you have a background in high performance sports, military service, or first response, how do you process research like this?
#ALS #EndALS #ALSResearch #ClinicalResearch #RareDisease #Neurology #Advocacy #ALSAwareness #ALSNewsToday #Bionews
1
0
0
0
The Latest ALS News: Expanded access program for ALS drug MN-166 at 50% enrollment. ALSNewsToday.com
ALS Access Update: https://bit.ly/3MtWLSG
An expanded access program for the experimental therapy MN 166 has reached fifty percent enrollment.
#ALS #ALSNewsToday #Bionews #ALSResearch #ExpandedAccess #ClinicalTrials #ALSTreatment #RareDiseaseNews
1
0
0
0
Read about ALS fatigue: https://bit.ly/3WJuQQh
From pacing your day to adjusting routines, small changes can help preserve energy and peace of mind.
#ALSNewsToday #ALSCommunity #ALS #AmyotrophicLateralSclerosis #FatigueAwareness #ALSSymptoms #ALSResearch #RareDiseaseCommunity #Bionews
0
0
0
0
"New in the ALS News: Computer model highlights the importance of timing in ALS treatment, focusing on spinal interneurons to preserve nerve function."
Explore why timing counts: https://bit.ly/49G8sPe
A new computer model study suggests targeting specific spinal nerve cells could help protect motor neurons in ALS, but only at the right stage of the disease.
#ALS #ALSAwareness #Neuroscience #RareDisease #Bionews #ALSResearch #ALSNewsToday
0
0
0
0
ALS News: New drug candidate targets toxic TDP 43 protein clumps, restoring normal function and reducing nerve cell damage.
Learn about a promising approach: https://bit.ly/4bgYCnY
A new experimental drug candidate targets toxic protein clumps linked to ALS and showed encouraging results in early studies. Researchers are now preparing for future human trials.
#ALS #ALSNewsToday #ALSResearch #Bionews
0
0
0
0
The latest ALS news highlights a study linking VCP mutations to nerve cell damage. Blocking VCP in lab models improved cell health.
New research spotlight: https://bit.ly/4r4wF7q
A new study suggests that in rare genetic forms of ALS, an overactive protein cleanup system linked to VCP mutations may damage nerve cells and disrupt how key proteins move within cells.
#ALS #ALSResearch #ALSNewsToday #Bionews
0
0
0
0
Headline announcing new research: Antibodies developed to target TDP-43 clumps in ALS, potentially reducing toxic proteins while preserving healthy ones.
New ALS research: https://bit.ly/4sGzahU
Scientists are studying antibodies designed to bind only the harmful form of the TDP 43 protein linked to most ALS cases while leaving the healthy version untouched.
#ALS #ALSResearch #NeurodegenerativeDisease #TDP43 #ALSNewsToday #Bionews
0
0
0
0
📣 Featured funding of the week!
💡 Milton Safenowits Postdoctoral Fellowship Program by ALS Association
🗓️ Deadline: Feb 10, 2026 | Letter of inquiry
🌍 Location: Global
💰 Amount: Up to 150,000 USD
🔗 Learn more: www.scientifyresearch.org/grant/the-mi...
#ALS #ALSAwareness #ALSResearch
0
0
0
0
Pallesthesia: https://bit.ly/4myfxFg
Pallesthesia, the sensation of a hum, was one of Dagmar Munn’s earliest ALS symptoms. Here’s how her body still feels when it’s doing its “humming thing.”
#ALS #ALSSymptoms #ALSResearch #ALSCommunity #ALSNewsToday #Bionews
0
0
0
0
"The Latest ALS News: APRTX-003 is an experimental RNA therapy for ALS, targeting MMP 9 enzyme to reduce nerve cell damage. Preclinical trials ongoing."
New ALS research: https://bit.ly/4qg1JkM
APRTX-003 is an experimental RNA based therapy designed to reduce MMP 9, an enzyme associated with nerve cell damage.
#ALSNewsToday #ALSResearch #ALSScience #NeurodegenerativeDisease #RareDiseaseNews #Bionews
0
0
0
0
Graphic with text: "The Latest ALS News." An early study finds QRL 101 reduced overactivity in motor neurons in ALS. Drug opens potassium channels, aiding neuron protection. Small trial shows safety, supporting Phase 2 trial. ALSNewsToday.com
New ALS research update: https://bit.ly/45kwEnJ
An early clinical study suggests QRL 101 may reduce harmful overactivity in motor neurons, a process linked to faster ALS progression.
#ALSResearch #ALSNewsToday #Bionews #ClinicalTrials #Neuroscience #MotorNeuronDisease #ALSCommunity
0
0
0
0
Text: "Health Canada has given its okay to an ongoing trial testing COYA 302 for ALS." Background: Close-up of cells.
Explore promising progress: https://bit.ly/4pupHaP
An ongoing ALS clinical trial is expanding to Canada, giving more people the opportunity to take part in research focused on slowing disease progression.
#ALS #ALSResearch #ClinicalTrials #ALSAwareness #RareDisease #ALSNewsToday #Bionews
0
0
0
0
Read about ALS fatigue: https://bit.ly/3WJuQQh
From pacing your day to adjusting routines, small changes can help preserve energy and peace of mind.
#ALSNewsToday #ALSCommunity #ALS #AmyotrophicLateralSclerosis #FatigueAwareness #ALSSymptoms #ALSResearch #RareDiseaseCommunity #Bionews
0
0
0
0
Read about ALS fatigue: https://bit.ly/3WJuQQh
From pacing your day to adjusting routines, small changes can help preserve energy and peace of mind.
#ALSNewsToday #ALSCommunity #ALS #AmyotrophicLateralSclerosis #FatigueAwareness #ALSSymptoms #ALSResearch #RareDiseaseCommunity #Bionews
0
0
0
0
Long-term data suggest newly approved therapy can change trajectory of a rare inherited form of ALS, with sustained gains in some patients.
longevity.technology/news/toferse...
#longevity #PrecisionMedicine #Neurodegeneration #ALSResearch #GenomicMedicine #Biotech
0
0
0
0
Headline: "New in the News: Device for slowing ALS progression wins FDA breakthrough status." Subheadline: "Noninvasive device delivers gentle electrical currents to nerves and spinal cord."
New ALS research update: https://bit.ly/45hfDun
A noninvasive device designed to deliver gentle electrical signals to nerves and the spinal cord has received FDA breakthrough status, a step meant to speed development for serious conditions like ALS.
#ALS #ALSNewsToday #ALSResearch #Bionews
0
0
0
0
New FDA-cleared Phase 3 trial of pridopidine for ALS focuses on timing and disease pace, showing potential benefits in function, breathing, and survival.
Learn what’s next: https://bit.ly/49feDcy
The FDA has cleared a pivotal Phase 3 trial of pridopidine, an oral therapy being studied in people early in ALS whose symptoms are progressing quickly.
#ALS #ALSNewsToday #Bionews #ALSResearch #ClinicalTrials #Pridopidine
0
0
0
0
Megaphone icon with the text: "Qalsody is designed to reduce a toxic protein linked to faster disease progression in people with SOD1 ALS – One step closer to being covered by public Canadian healthcare systems."
Learn about treatment progress: https://bit.ly/4p1b9z4
A gene targeted therapy for SOD1 related ALS is gaining attention as access decisions move forward. Read more to understand what this therapy does.
#ALS #ALSResearch #SOD1ALS #ALSTreatment #ALSNewsToday #Bionews
0
0
0
0
New study shows blood genetic activity may help detect ALS and predict survival. Source: ALS News Today.
New ALS research insight: https://bit.ly/3MvvhvR
A new study suggests that patterns of genetic activity in blood may help detect ALS earlier and even offer clues about survival.
#ALS #ALSResearch #NeurodegenerativeDisease #RareDiseaseResearch #ALSNewsToday #Bionews
0
0
0
0